Hospital Británico de Buenos Aires-Oncology ( Site 1106)

Ciudad Autónoma de Buenos Aires, Buenos Aires C1280AEB

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). — Running, not enrolling